1. AB0611 Mycophenolate mofetil for the treatment of inflammatory myopathy related interstitial lung disease: a systematic review. (15th June 2017) Authors: Lopez, B; Isenberg, DA; Gordon, PA Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0132 Myositis and pregnancy. (1st June 2001) Authors: Silva, CA; Isenberg, DA Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SP0152 Learning from clinical trials in systemic lupus erythematosus. (15th June 2017) Authors: Isenberg, DA Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0152 Disease activity and damage scores correlated differently with the patient reported outcomes in patients with primary SJÖGREN'S syndrome compared to lupus associated with secondary SJÖGREN'S syndrome. (15th June 2017) Authors: Thompson, N; Gupta, V; Gandhi, A; Radmore, R; Cho, S; Isenberg, DA; Jury, EC; Ciurtin, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S7A:5 Sri response, attainment of low disease activity and safety in patients with systemic lupus treated with atacicept in a phase iib study (address ii). (21st March 2018) Authors: Merril, JT; Morand, E; Wallace, DJ; Kao, A; Vazquez-Mateo, C; Chang, P; Fleuranceau-Morel, P; Isenberg, DA Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S7A:4 Reduction of systemic lupus flares by atacicept in a randomised, placebo-controlled, phase iib study (address ii) and its extension study. (21st March 2018) Authors: Wallace, DJ; Isenberg, DA; Kao, A; Vazquez-Mateo, C; Fleuranceau-Morel, P; Chang, P; Merril, JT Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S15.2 Severe non-adherence to hydroxychloroquine is associated with flares, early damage, and mortality in systemic lupus erythematosus: data from 660 patients from the slicc inception cohort. (27th September 2022) Authors: Nguyen, Y; Blanchet, B; Urowitz, MB; Hanly, JG; Gordon, C; Bae, S; Romero-Dia, J; Sanchez-Guerrero, J; Clarke, AE; Bernatsky, S; Wallace, DJ; Isenberg, DA; Rahman, A; Merrill, JT; Fortin, PR; Gladman, DD; Bruce, IN; Petri, M; Ginzler, EM; Dooley, MA Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease. (March 2014) Authors: Khamashta, MA; Bruce, IN; Gordon, C; Isenberg, DA; Ateka-Barrutia, O; Gayed, M; Donatti, C; Guillermin, A-L; Foo, J; Perna, A Journal: Lupus Issue: Volume 23:Number 3(2014) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Drug-induced lupus: Including anti-tumour necrosis factor and interferon induced. (May 2014) Authors: Araújo-Fernández, S; Ahijón-Lana, M; Isenberg, DA Other Names: Costenbader Karen guest-editor.; Edwards Christopher guest-editor. Journal: Lupus Issue: Volume 23:Number 6(2014) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗